Literature DB >> 25742264

Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation.

Alice Tung Wan Song1, Evandro Sobroza de Mello2, Venâncio Avancini Ferreira Alves2, Norma de Paula Cavalheiro3, Carlos Eduardo Melo3, Patricia Rodrigues Bonazzi1, Fatima Mitiko Tengan3, Maristela Pinheiro Freire4, Antonio Alci Barone3, Luiz Augusto Carneiro D'Albuquerque1, Edson Abdala1.   

Abstract

Histology is the gold standard for diagnosing acute rejection and hepatitis C recurrence after liver transplantation. However, differential diagnosis between the two can be difficult. We evaluated the role of C4d staining and quantification of hepatitis C virus (HCV) RNA levels in liver tissue. This was a retrospective study of 98 liver biopsy samples divided into four groups by histological diagnosis: acute rejection in patients undergoing liver transplant for hepatitis C (RejHCV+), HCV recurrence in patients undergoing liver transplant for hepatitis C (HCVTx+), acute rejection in patients undergoing liver transplant for reasons other than hepatitis C and chronic hepatitis C not transplanted (HCVTx-). All samples were submitted for immunohistochemical staining for C4d and HCV RNA quantification. Immunoexpression of C4d was observed in the portal vessels and was highest in the HCVTx- group. There was no difference in C4d expression between the RejHCV+ and HCVTx+ groups. However, tissue HCV RNA levels were higher in the HCVTx+ group samples than in the RejHCV+ group samples. Additionally, there was a significant correlation between tissue and serum levels of HCV RNA. The quantification of HCV RNA in liver tissue might prove to be an efficient diagnostic test for the recurrence of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25742264      PMCID: PMC4371218          DOI: 10.1590/0074-02760140192

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  51 in total

1.  Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts.

Authors:  M Mengel; S Chan; J Climenhaga; Y B Kushner; H Regele; R B Colvin; P Randhawa
Journal:  Am J Transplant       Date:  2013-03-06       Impact factor: 8.086

2.  Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants.

Authors:  K L Aardema; R E Nakhleh; L K Terry; E M Burd; C K Ma; D K Moonka; K A Brown; M S Abouljoud
Journal:  Mod Pathol       Date:  1999-11       Impact factor: 7.842

3.  Cold activation of serum complement in patients with chronic hepatitis C: study on activating pathway and involvement of IgG.

Authors:  Y Ishii; H Shimomura; M Itoh; M Miyake; F Ikeda; J Miyaike; S Fujioka; Y Iwasaki; H Tsuji; T Tsuji
Journal:  Acta Med Okayama       Date:  2001-08       Impact factor: 0.892

4.  Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection.

Authors:  Anja Dankof; Maximilian Schmeding; Lars Morawietz; Raphaela Günther; Manfred G Krukemeyer; Birgit Rudolph; Martin Koch; Veit Krenn; Ulf Neumann
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

5.  The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.

Authors:  M J Gottschlich; K L Aardema; E M Burd; R E Nakhleh; K A Brown; M S Abouljoud; K Hirst; D K Moonka
Journal:  Liver Transpl       Date:  2001-05       Impact factor: 5.799

6.  Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection.

Authors:  Gerard J Nuovo; Amy Holly; Paul Wakely; Wendy Frankel
Journal:  Hum Pathol       Date:  2002-03       Impact factor: 3.466

Review 7.  Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.

Authors:  Sammy Saab; Victor Wang
Journal:  J Clin Gastroenterol       Date:  2003-08       Impact factor: 3.062

8.  Recurrent allograft HCV presenting as acute cellular rejection: successful management with interferon and ribavirin alone.

Authors:  Jessica Y Leung; Diane R Abraczinskas; Atul K Bhan; Adam M Terella; Manuel Pascual; A Benedict Cosimi; Raymond T Chung
Journal:  Clin Transplant       Date:  2003-06       Impact factor: 2.863

9.  Natural history of recurrent hepatitis C.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

Review 10.  Pathogenesis of hepatitis C virus recurrence in the liver allograft.

Authors:  Geoffrey W McCaughan; Amany Zekry
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.